Objective Classic features of type 1 and type 2 diabetes may not apply in Asian Americans, due to shared absence of common HLA DR-DQ genotype, low prevalence of positive anti-islet antibodies and low BMI in both types of diabetes. Our objective was to characterize diabetic phenotypes in Asian Americans by clamp and clinical features. Materials/Methods This was a cross-sectional study conducted in a referral center. Thirty East young Asian American adult volunteers (27.6±5.5 years) with type 1, type 2 diabetes or controls underwent hyperinsulinemic euglycemic clamp to assess insulin resistance and DEXA to assess adiposity. Results Gender, BMI, waist/hip ratio, leptin, LDL, anti-GAD, anti-IA2 antibodies and C-reactive protein were similar among three groups. Serum C-peptide, adiponectin, free fatty acid, HDL concentrations and truncal fat by DEXA, were different between diabetic groups. Glucose disposal rate by clamp was lowest in type 2 diabetes, followed by type 1 diabetes and controls (5.43±2.70, 7.62±2.59, 8.61±2.37 mg/min/kg, respectively, p = 0.001). Free fatty acid concentration universally plummeted during steady state of the clamp procedure regardless of diabetes types in all three groups. Adipocyte fatty acid binding protein in the entire cohort (r = ？0.625, p = 0.04) and controls (r = ？0.869, p = 0.046) correlated best with insulin resistance, independent of BMI. Conclusions Type 2 diabetes in Asian Americans was associated with insulin resistance despite having low BMI as type 1 diabetes, suggesting a potential role for targeting insulin resistance apart from weight loss. Adipocyte fatty acid binding protein, strongly associated with insulin resistance, independent of adiposity in the young Asian American population, may potentially serve as a biomarker to identify at-risk individuals. Larger studies are needed to confirm this finding.
References
[1]
International Diabetes Federation (2009) IDF Diabetes Atlas, 4th ed. Brussels, Belgium: International Diabetes Federation.
[2]
Fujimoto WY, Leonetti DL, Kinyoun JL, Newell-Morris L, Shuman WP, et al. (1987) Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes 6: 721–729.
[3]
Thorpe LE, Upadhyay UD, Chamany S, Garg R, Mandel-Ricci J, et al. (2009) Prevalence and control of diabetes and impaired fasting glucose in New York City. Diabetes Care 1: 57–62.
[4]
Todd AL, Ng WY, Lui KF, Thai AC (2004) Low prevalence of autoimmune diabetes markers in a mixed ethnic population of Singaporean diabetics. Intern Med J 34: 24–30.
[5]
Park Y, Eisenbarth GS (2001) Genetic susceptibility factors of type 1 diabetes in Asians. Diabetes Metab Rev 17: 2–11.
[6]
McNeely MJ, Boyko EJ (2004) Type 2 diabetes prevalence in Asian Americans: results of a national health survey. Diabetes Care 27: 66–69.
[7]
Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, et al. (2009) Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 20: 2129–2140.
[8]
Kadowaki T, Sekikawa A, Murata K, Maegawa H, Takamiya T, et al. (2006) Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study. Int J Obes (Lond) 30: 1163–1165.
[9]
Raji A, Gerhard-Herman MD, Warren M, Silverman SG, Raptopoulos V, et al. (2004) Insulin resistance and vascular dysfunction in nondiabetic Asian Indians. J Clin Endocrinol Metab 89: 3965–3972.
[10]
Maskarinec G, Grandinetti A, Matsuura G, Sharma S, Mau M, et al. (2009) Diabetes prevalence and body mass index differ by ethnicity: the Multiethnic Cohort. Ethn Dis 19: 49–55.
[11]
Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, et al. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354: 2552–2563.
[12]
Jia W, Wu H, Bao Y, Wang C, Lu J, et al. (2007) Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab 92: 3224–3229.
[13]
Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, et al. (2007) Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 115: 1537–1543.
[14]
Tso AW, Xu A, Sham PC, Wat NM, Wang Y, et al. (2007) Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 30: 2667–2672.
[15]
American Diabetes Association (2009) Diagnosis and classification of diabetes mellitus. Diabetes Care S62–67:
[16]
Diabetes Prevention Program Research Group (2005) Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program. Diabetes Care 28: 2472–2479.
[17]
Chiu KC, Cohan P, Lee NP, Chuang LM, et al. (2000) Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function. Diabetes Care 23: 1353–1358.
